The catalogue, as a graph

The replica pages show what IRIS looks like. This one shows what this catalogue knows — and, more usefully, what it records that it does not know.

The gap is the point, not a backlog. This instance models 235 node(s) against 273,559 items across 1,057,223 files upstream. Cataloguing by reference means recording that something exists without holding it, so a small number here is the design rather than a shortfall.

What is held, and what is only named

statenodeswhat it means
materialized182the bytes are in this repository
referenced53upstream, not here — a fact, not a gap
unknown0nobody has looked; never rendered as either of the above

What the gates say about the 419 held bitstream(s)

Not everything permitted is everything known. sourceLoss is unknown on 172 of them. A gate that returned unknown is a question nobody has answered — which is a different state from a gate that was asked and said yes, and collapsing the two would turn an open question into a clearance.

gateverdicts
copyrightpermitted: 184 of 184
restrictionspermitted: 184 of 184
retentionpermitted: 184 of 184
sizepermitted: 184 of 184
sourceLosspermitted: 12 of 184 unknown: 172 of 184

Every node

materializeditemYELLOW-FEVER VACCINATING CENTRES FOR INTERNATIONAL TRAVEL = CENTRES DE VACCINATION CONTRE LA FIÈVRE JAUNE POUR LES VOYAGES INTERNATIONAUX
item/004bc4fd-f0e5-469f-a573-0a4ce2ed7615
10665-218202 · item pageyes2
materializeditemYELLOW FEVER : DESIGNATED VACCINATING CENTRES = FIÈVRE JAUNE : CENTRES DE VACCINATION HABILITÉS
item/00cb6d29-a805-405d-b0bc-9cc70b27da67
10665-214276 · item pageyes2
materializeditemLa OMS recomienda la adopción de enfoques basados en las redes de contactos para la realización de pruebas del VIH en los grupos de población clave, en el marco de un conjunto de servicios para las parejas: sinopsis de políticas
item/03195f06-0dea-4665-b969-755578eedd19
10665-341918 · item pageyes2
materializeditemTables rondes : enseignements tirés en matière de santé mondiale : Rapport du Secrétariat
item/03285c86-f7cc-40f1-ad16-82958cbdfd76
10665-83270 · item pageyes2
materializeditemYELLOW FEVER : DESIGNATED VACCINATING CENTRES = FIÈVRE JAUNE : CENTRES DE VACCINATION HABILITÉS
item/0515f6d9-5c00-48f5-878b-5f1cdc3f739a
10665-211583 · item pageyes2
materializeditemDigital adaptation kit for antenatal care: operational requirements for implementing WHO recommendations in digital systems
item/0577a503-687f-4ce5-a92f-e126570de444
10665-339745 · item pageyes2
materializeditem[Pilot study of antiretroviral therapy in Djibouti]
item/079b647b-b2e8-4b5b-ad36-9ee6b8df2ce8
10665-117378 · item pageyes2
materializeditemClassification of digital interventions, services and applications in health: a shared language to describe the uses of digital technology for health
item/08c17880-005f-41a2-87f0-14f2bc1761bb
9789240081949-eng · item pageyes1
materializeditemЦифровое здравоохранение
item/09cb3e6a-2836-41a1-b5d8-5550717174a2
10665-279508 · item pageyes2
materializeditemЛечение и уход в связи с ВИЧ/СПИДом в Беларуси: отчет оценочной миссии: январь 2014 г.
item/12b9c85a-2fb4-4c35-9b23-5b70d344b11c
10665-350543 · item pageyes1
materializeditemIMMUNIZATION SURVEY - 1970 = ENQUÊTE SUR LES VACCINATIONS — 1970
item/13365de7-82f7-4d8b-a20c-637b65101eca
10665-218295 · item pageyes2
materializeditemThe MAPS Toolkit: mHealth Assessment and Planning for Scale
item/1469660e-9540-46b6-9401-510f4e4b8a35
9789241509510-eng · item pageyes1
materializeditemWHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention
item/16652e25-1204-4d55-910b-9df5fd952f80
10665-342365 · item pageyes2
materializeditemPreparación de las introducción de las vacunas contra el virus del papiloma humano : orientaciones normativas y programáticas para los países
item/17f1f696-9c42-4db5-95aa-c8cbfc43f812
10665-69654 · item pageyes2
materializeditemDigital transformation handbook for reporting substandard and falsified medical products
item/187cabc7-3e82-412e-8cbb-1502a9da36ad
9789240120747-eng · item pageyes2
materializeditemPublication and information products style guide
item/18892cf3-5a4f-42a4-923c-a93f4a594dec
wpr-rdo-2020-003-eng · item pageyes2
materializeditemОчередной обзор программ вакцинации БЦЖ
item/1ae14a32-287f-485f-a743-7acb079ae7ec
10665-174300 · item pageyes2
materializeditemÉtude de l'immunité humorale et cellulaire après vaccination antitétanique chez l'enfant africain malnutri et paludéen : 1 : étude de la réponse en anticorps antitétaniques
item/1bf24e0d-f1ad-472f-ae14-d4efbeb0adc1
10665-264857 · item pageyes2
materializeditemDigital implementation investment guide (DIIG): integrating digital interventions into health programmes
item/1dc5ea7b-7de5-4814-876c-1ee302538f84
9789240010567-eng · item pageyes1
materializeditemProgramme élargi de vaccination (résolution)
item/2031a33d-3f6e-4b76-9083-7dde1290f461
10665-249224 · item pageyes2
materializeditemYELLOW FEVER : DESIGNATED VACCINATING CENTRES = FIÈVRE JAUNE : CENTRES DE VACCINATION HABILITÉS
item/2122a70b-9dc1-449e-855f-5153f29d4a1f
10665-209646 · item pageyes2
materializeditemConsolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact
item/21348ffd-191c-4f90-9aae-111fbd7e0637
10665-360948 · item pageyes2
materializeditemConsolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations
item/23e06701-7195-4c84-8e5c-a3d204669a9b
10665-360601 · item pageyes2
materializeditemComprehensive package of care for infants and young children exposed to HIV: policy brief
item/24f93719-ebfa-4d26-a775-6909eff6b238
10665-350214 · item pageyes2
materializeditemPandemic influenza preparedness framework: annual progress report, 1 January – 31 December 2022
item/250d4dd2-3885-4c7b-be27-40e18b70195a
10665-372197 · item pageyes2
materializeditemThe use of loop-mediated isothermal amplification (TB-LAMP) for the diagnosis of pulmonary tuberculosis: policy guidance
item/27e31e9f-fb42-45c7-affb-7fd72e901998
10665-249154 · item pageyes2
materializeditemSANITARY MEASURES : VACCINATION CERTIFICATE REQUIREMENTS FOR INTERNATIONAL TRAVEL = MESURES SANITAIRES : CERTIFICATS DE VACCINATION EXIGÉS DANS LES VOYAGES INTERNATIONAUX
item/295b87d7-2725-4d1c-aa4d-eda3ce79559c
10665-215678 · item pageyes2
materializeditemPreparación para una gripe pandémica: marco para el intercambio de virus gripales y el acceso a las vacunas y otros beneficios
item/2afa96a2-1917-49c7-87b8-91b7a3744cdd
10665-44867 · item pageyes2
materializeditemProgramme d'action pour les médicaments et vaccins essentiels: projet de résolution proposé par le Président du Comité ad hoc et les Rapporteurs
item/2d273df0-e7db-4aa6-a359-0d66cb8daaf9
10665-174553 · item pageyes2
materializeditemEstrategia mundial sobre salud digital 2020–2025
item/2da90ddf-7e77-409f-86ab-a34497747b2d
10665-344251 · item pageyes2
materializeditemPlan stratégique de l' Initiative mondiale pour l' éradication de la poliomyélite : 2004-2008
item/2e7f2a3e-5f0a-4eb9-98a6-b4a019a073ba
10665-42988 · item pageyes2
materializeditemHIV diagnosis and ARV use in HIV-exposed infants: a programmatic update
item/2e9f9882-cb0e-4a2a-ac56-25d4395b4920
10665-273155 · item pageyes3
materializeditemWHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection: module 10: testing providers
item/3168fd16-f506-4b2c-9244-d5d12e0fe166
10665-258516 · item pageyes2
materializeditemDigital transformation handbook for primary health care
item/32a98265-3e71-42fa-afdc-e7f62cc2622c
9789240093362-eng · item pageyes1
materializeditemCounselling for HIV/AIDS : a key to caring, for policy-makers, planners and implementors of counselling activities
item/32cf89b2-a0fa-4fc7-a32c-a2ed0006a2f6
10665-58534 · item pageyes2
materializeditemSanté numérique
item/33d66c57-8356-4d35-ac24-74533f3444d8
10665-279507 · item pageyes2
materializeditemWHO recommends social network-based HIV testing approaches for key populations as part of partner services package: policy brief
item/34b20c11-d360-485c-a33b-803ad6f3ece5
10665-329964 · item pageyes4
materializeditemSecond meeting of the Global Working Group on TB/HIV : 14-16 June 2002, Durban, South Africa
item/36b2da32-d0c4-4267-a8db-60f114f27906
10665-67839 · item pageyes2
materializeditemAlocución del Director General a la 58ª Asamblea Mundial de la Salud: Ginebra, lunes 16 de mayo de 2005
item/381beb06-b062-4a23-a689-49b2729c3e25
10665-22470 · item pageyes2
materializeditemWay and Means of Implementing Resolutions of Regional Interest Adopted by the World Health Assembly and the Executive Board Report of the Regional Director
item/392a26b7-abd7-4726-84d5-5a636025385c
10665-92871 · item pageyes2
materializeditemGuidelines: updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring
item/396e27dd-8532-4243-b4b5-bff30eeebc1b
10665-340190 · item pageyes2
materializeditemExpanded Programme on Immunization (EPI) : Progress towards poliomyelitis eradication, WHO Western Pacific Region, January 1996-September 1997 = Programme élargi de vaccination (PEV) : Progrès réalisés vers l’éradication de la poliomyélite, Région OMS du Pacifique occidental, janvier 1996-septembre 1997
item/3b1fb2d4-cc87-4b9f-b5a5-91116db6a9e6
10665-230330 · item pageyes2
materializeditemPrevention of HIV in infants and young children : review of evidence and WHO's activities
item/3d0c56a3-7953-400c-a019-e431a57f69f3
10665-67344 · item pageyes2
materializeditemDigital adaptation kit: family planning: operational requirements for implementing WHO recommendations in digital systems
item/3ebee794-2724-464d-be31-d6f4d3975c9a
10665-341997 · item pageyes2
materializeditemWHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection: module 3: counsellors
item/3f025641-c57d-44c8-97c5-ee458cb7e50c
10665-258517 · item pageyes2
materializeditemLa supplémentation en iode par voie buccale ne réduit pas la réponse en anticorps neutralisants au vaccin antipoliomyélitique buccal / R. E. Taffs ... [et al.]
item/457a143e-3140-4be4-b78a-c740fe923266
10665-72461 · item pageyes2
materializeditemVaccins antivarioliques secs
item/4695734e-0284-43f1-9a87-df07e115fdb7
10665-266214 · item pageyes2
materializeditem8th National Tuberculosis Programme Managers Meeting and 13th Wolfheze Workshop: Wolfheze 2008: tuberculosis management, surveillance and evaluation in Europe with high rates or threat of multidrug resistant tuberculosis: The Hague, the Netherlands, 1–2 June 2008
item/477df671-50cb-4df8-bc84-de837477c1d1
10665-107919 · item pageyes2
materializeditemLe diagnostic du VIH et l’utilisation des ARV chez le nourrisson exposé au virus : mise à jour programmatique
item/496813f5-1733-4acf-ba2b-249e74151c3a
10665-329296 · item pageyes2
materializeditemПроект четвертого доклада Комитета А
item/4b94e368-8ad1-4e4a-a1a2-70f2aa9ccd26
10665-111245 · item pageyes2
materializeditemGateways to integration : a case study from Swaziland: in support of the global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive
item/4ecd5dca-2f99-4ef6-ac00-201cb7424b6a
10665-102762 · item pageyes2
materializeditem区域主任关于区域关键性业务和管理改革问题战略和进展的报告:非洲区域主任的报告
item/4f41c22c-d9aa-4e93-bd95-472cf7269d20
10665-198389 · item pageyes2
materializeditemDigital adaptation kit for immunizations: operational requirements for implementing WHO recommendations in digital systems
item/50d01818-0fa6-43d4-a39e-5bfae735c547
9789240099456-eng · item pageyes2
materializeditemMonitoring and Evaluating Digital Health Interventions: A practical guide to conducting research and assessment
item/53de8b1c-5a9a-40b7-8a48-9d1717de4cb7
9789241511766-eng · item pageyes1
materializeditemPolicy brief: update of recommendations on first- and second-line antiretroviral regimens
item/553ef669-75fd-4f15-8873-964b2964ed33
10665-325892 · item pageyes2
materializeditemLeave no one behind: guidance for planning and implementing catch-up vaccination
item/58333fc5-9ec5-4d14-b341-5ae257dd0ad1
9789240016514-eng · item pageyes2
materializeditemWHO operational handbook on tuberculosis: module 1: prevention: tuberculosis preventive treatment
item/5a424083-9251-4a06-955b-9952ee43b480
10665-331525 · item pageyes3
materializeditemتصنيف التدخلات والخدمات والتطبيقات الرقمية في مجال الصحة: لغة مشتركة لوصف استخدامات التكنولوجيا الرقمية من أجل الصحة
item/5cdd0488-c714-4542-9752-31cc9b4e9f9a
10665-379160 · item pageyes2
materializeditem卫生组织防治获得性免疫缺损综合症的活动
item/5e232af1-15cb-470b-a5fe-80c839dbf703
10665-195658 · item pageyes2
materializeditem数字卫生保健
item/5eba8bf9-1c22-403b-805b-393894512843
10665-279509 · item pageyes2
materializeditemPre-qualification of single-use injection devices under the PQS system : a guideline for manufacturers
item/607e9522-b55c-40c0-9de2-0ef647cae24a
10665-69096 · item pageyes2
materializeditemReview and evaluation of specific programmes: global programme for vaccines and immunization
item/6359cac0-74fd-486e-844f-0603677bc5cd
10665-172302 · item pageyes2
materializeditemWHO consolidated guidelines on tuberculosis: module 2: screening: systematic screening for tuberculosis disease
item/636231e5-1835-4721-8edb-6b2fecf4b5cd
10665-340255 · item pageyes2
materializeditemThe immunological basis for immunization series: module 16: mumps
item/63869fc2-c124-4de6-8dfc-2ac36e558d86
10665-97885 · item pageyes2
materializeditemCost-effectiveness of introducing the pneumococcal conjugate vaccine for children under 5 years in the Islamic Republic of Iran
item/638b31e3-ec3e-424c-ac12-53d5ed2fdb73
10665-385346 · item pageyes2
materializeditemWHO handbook for guideline development
item/63e14c27-7448-41ec-be08-a96a25a47db6
9789241548960-eng · item pageyes2
materializeditemControl of smallpox in Delhi Municipal Corporation / by P.H. Jeswani
item/648f2853-6ecb-4901-8d1b-f5d1ce79206e
10665-68092 · item pageyes2
materializeditemLa vaccination dans le monde : vision et stratégie : rapport du Secrétariat
item/65954fd1-f19b-4961-94c6-5a376317ad2f
10665-3278 · item pageyes2
materializeditemEnumeration of CD4 T lymphocytes : report of a workshop, Bangkok, Thailand, 6-10 June 2006
item/6804fe89-6428-45f8-9e42-95097eb5e1cf
10665-205022 · item pageyes2
materializeditemInmunización contra la Hepatitis B : introducción de la vacuna contra la hepatitis B en los servicios nacionales de inmunización
item/68919b30-c4b0-48de-9f56-6494b79f3e29
10665-67212 · item pageyes2
materializeditemCartographie du risque de fièvre jaune et vaccination antiamarile recommandée pour les voyageurs : projet de résolution proposé par l’Argentine
item/6a10dfe6-79e4-475d-b989-c0a405028f27
10665-252004 · item pageyes2
materializeditemStratégie Mondiale de lutte contre le SIDA
item/6b357978-7516-423f-9689-e3200cdfb0f1
10665-179526 · item pageyes2
materializeditemPossibilités d'amélioration des vaccins anticholériques et méthodes d'évaluation de leur efficacité
item/6c91e7df-332b-461e-8a75-cb98a6d138e2
10665-266751 · item pageyes2
materializeditemPandemic Influenza Preparedness Framework for the sharing of influenza viruses and access to vaccines and other benefits: draft decision proposed by Secretariat with amendments by Member States
item/6ec85847-4127-4240-9812-498bc99fd42a
10665-327942 · item pageyes2
materializeditemINOCULATION AND VACCINATION CERTIFICATES REQUIRED BY VARIOUS COUNTRIES = CERTIFICATS DE VACCINATION EXIGÉS PAR LES DIVERS PAYS
item/6f0c54f0-8b69-4860-b090-afac02060d91
10665-239877 · item pageyes2
materializeditemCaracteristiques d' activité et de stabilité des vaccines antivarioliques utilisés dans les programmes d' éradication de la variole en Afrique de l' ouest et du centre-ouest / par A. Bernstein et M.Z. Bierly
item/6f419826-fade-41c1-91a1-790f95fad993
10665-67518 · item pageyes2
materializeditemTechnical update: considerations for developing a monitoring and evaluation framework for viral load testing: collecting and using data for scale-up and outcomes
item/71ce00ae-9c17-4a74-b116-a2c106f42452
10665-324745 · item pageyes2
materializeditemThe importance of assessing self-reported HIV status in bio-behavioural surveys
item/72ed2008-130f-473f-9db4-8d594c041520
10665-271946 · item pageyes2
materializeditemYELLOW-FEVER VACCINATING CENTRES FOR INTERNATIONAL TRAVEL = CENTRES DE VACCINATION CONTRE LA FIÈVRE JAUNE POUR LES VOYAGES INTERNATIONAUX
item/743fbbaf-b6b8-4327-82e0-c7db3788ee90
10665-217807 · item pageyes2
materializeditemПредварительные рекомендации по применению инактивированной вакцины CoronaVac против COVID-19, разработанной Sinovac: Временное руководство (Первый выпуск 24 мая 2021 г., Обновлено 21 октября 2021 г., Обновлено 15 марта 2022 г.)
item/75ac2e73-7a9f-4edd-8973-1c15bee40bdf
10665-354214 · item pageyes2
materializeditemAdverse events monitoring as a routine component of vaccine clinical trials: evidence from the WHO Vaccine Trial Registry.
item/75acc543-c691-4693-97d8-8d5edfd3ee6a
10665-268219 · item pageyes2
materializeditemWHO consolidated guidelines on tuberculosis: module 3: diagnosis: web annex B: evidence synthesis and analysis
item/76743201-caec-42ac-83d9-f86c33f59864
10665-381036 · item pageyes2
materializeditemJob aid for COVID-19 vaccine administration: Janssen–Cilag International NV (Belgium) Ad26.COV2.S COVID-19 vaccine (international non-proprietary name: Ad26.COV2.S COVID-19 Vaccine)
item/77643e31-6da6-416d-842b-ed9e8ef0cdcc
10665-342490 · item pageyes2
materializeditemClasificación de intervenciones, servicios y aplicaciones digitales en salud: un lenguaje compartido para describir los usos de la tecnología digital para la salud
item/776ee926-430a-4031-891b-83788c96f724
10665-379033 · item pageyes2
materializeditemLignes directrices de l'OMS : recommandations sur les interventions numériques pour le renforcement des systèmes de santé
item/780b5573-ba80-4b1a-9ce7-a50faf66a45a
10665-354400 · item pageyes2
materializeditemActa resumida de la primera sesión
item/79264c53-7e20-4d0e-b3e6-c3cb24d1823c
10665-145614 · item pageyes2
materializeditemSexual and reproductive health and rights: infographic snapshot: North Macedonia 2021
item/7a204a7b-be3f-4fde-aaab-d4c30f7f49c2
10665-349683 · item pageyes2
materializeditemДоклады о ходе работы: доклад Секретариата
item/7bd60d5c-87c7-48e4-b726-fa8c895517a1
10665-25966 · item pageyes2
materializeditemStratégie mondiale pour la santé numérique 2020-2025
item/7d0f8ec2-c315-4992-ac15-c07c63706ce7
10665-344250 · item pageyes2
materializeditemBreastfeeding and replacement feeding practices in the context of mother-to-child transmission of HIV : an assessment tool for research
item/7e9892c6-6576-4cbf-bd84-6ea6f2174ae1
10665-67132 · item pageyes2
materializeditemUnderstanding national health workforce accounts
item/81b0f40b-5dbc-491d-a2ac-b63c7f3f9f27
who-his-hwf-nhwa-20171-eng · item pageyes1
materializeditemPreparing for the introduction of HPV vaccines : policy and programme guidance for countries
item/81bcbc9a-5310-4ef7-bb0b-f9fd5ebe13f2
10665-69384 · item pageyes5
materializeditemMENINGOCOCCAL POLYSACCHARIDE VACCINES = VACCINS ANTIMÉNINGOCOCCIQUES POLYOSIDIQUES
item/82254932-5a04-43d0-8035-a7bdda597fdd
10665-222160 · item pageyes2
materializeditemVACCINATION CERTIFICATE REQUIREMENTS FOR INTERNATIONAL TRAVEL = CERTIFICATS DE VACCINATION EXIGÉS DANS LES VOYAGES INTERNATIONAUX
item/84f32c15-6d98-4868-9afa-8981781e4db2
10665-220134 · item pageyes2
materializeditemRoutine immunization profile: Switzerland
item/85c59db3-c4a9-454f-ab81-320d598cc280
10665-347190 · item pageyes2
materializeditemDifferentiated and simplified pre-exposure prophylaxis for HIV prevention: update to WHO implementation guidance: technical brief
item/8718826e-a3cf-4583-8951-06b4f5aa7c7c
10665-360861 · item pageyes2
materializeditem甲委员会第一份报告:(草案)
item/89d07373-2aea-47e0-9636-45fec9167520
10665-83077 · item pageyes2
materializeditemGuidelines on long-acting injectable cabotegravir for HIV prevention
item/89df0258-5433-4616-a801-8668d6f20f64
10665-360869 · item pageyes2
materializeditemGuía para la inversión en la implementación digital (DIIG): incorporación de intervenciones digitales en los programas de salud
item/8a2ee88d-ed7f-4230-a1fd-6d17024d12d2
10665-353151 · item pageyes2
materializeditemТретий доклад Комитета А : (проект)
item/8af47662-e100-4d55-b32f-f04f4ed29c40
10665-81619 · item pageyes2
materializeditemThiomersal as a vaccine preservative = L’utilisation du thiomersal comme conservateur pour vaccins
item/8c1a81ea-9604-44b4-93ae-17e827d78982
10665-231031 · item pageyes2
materializeditemWHO recommendations on maternal health: guidelines approved by the WHO Guidelines Review Committee
item/8cff86ad-e9e0-4bc3-9863-a808b46c1159
10665-259268 · item pageyes2
materializeditemSalud digital
item/8ebb5954-d41e-41d6-ab4a-09a4eec958e4
10665-279506 · item pageyes2
materializeditemThe immunization data quality self-assessment (DSQ) tool
item/8fb9825a-c9b2-45eb-abbf-0f8d4a173641
10665-69034 · item pageyes2
materializeditemPandemic influenza preparedness framework for the sharing of influenza viruses and access to vaccines and other benefits
item/90f496bc-2c48-473c-be94-cb0d2b2a22c4
10665-44796 · item pageyes5
materializeditemWHO recommendations on home-based records for maternal, newborn and child health
item/91c56414-8470-4e35-83ad-0079c589d5fc
10665-274277 · item pageyes2
materializeditemInformation, education and communication: a guide for AIDS programme managers
item/922d38a3-f088-47e3-9eed-85f7dd37a30a
10665-205344 · item pageyes2
materializeditemJoint and cosponsored United Nations programme on HIV/AIDS (draft resolution proposed by Professor Munevver Bertan, Professor J. M. S. Caldeira da Silva, Professor I. Chernozemsky, Dr V. Devo, Mrs P. Herzog, Dr J. Larivière, Dr J. G. S. Makumbi, Professor J. Mbede, Dr E. Nakamura, Dr Ngo Van Hop, Dr B. L. Shrestha and Mr J. F. Varder)
item/94009fa3-2fe2-4d97-948b-2ac74a1ebe42
10665-172045 · item pageyes2
materializeditemPoliomyélite : intensification de l’Initiative mondiale pour l’éradication de la poliomyélite : rapport du Secrétariat
item/9562ab39-7e32-4f2d-9692-6947ed1f26de
10665-24399 · item pageyes2
materializeditemHIV : to test or not to test?
item/95abf607-9c77-4185-8dbd-185fef57b936
10665-47547 · item pageyes2
materializeditemClassification des interventions, des services et des applications numériques dans le domaine de la santé : un langage commun pour décrire les diverses utilisations de la technologie numérique dans le domaine de la santé
item/96acb6a8-9df0-4668-8f84-c334dbd51a4a
10665-378873 · item pageyes2
materializeditemDigital documentation of COVID-19 certificates: vaccination status: technical specifications and implementation guidance, 27 August 2021
item/96b90d2c-5e33-404d-b7a5-5601bac140bc
who-2019-ncov-digital-certificates-vaccination-20211-eng · item pageyes2
materializeditemVaccination contre l' hépatite B : introduire le vaccin contre l' hépatite B dans les services nationaux de vaccination
item/96c8930e-0f98-4962-8d9b-9b453592eda9
10665-67211 · item pageyes2
materializeditemClassification of Digital Health Interventions v1.0
item/98c528f1-48f0-4803-9a11-c83cd2e52c17
who-rhr-1806-eng · item pageyes1
materializeditemWHO recommendations on antenatal care for a positive pregnancy experience
item/9a90617b-f771-4d4d-a538-a51f87c51685
9789241549912-eng · item pageyes3
materializeditemWHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment
item/9c30490a-8485-4eb7-8549-1209413fdc5f
10665-331170 · item pageyes3
materializeditemNational eHealth strategy toolkit
item/9cc67c08-78e6-432a-996e-0fa06f47e6ce
10665-75211 · item pageyes5
materializeditemNational health accounts
item/9de774be-825d-4d81-8518-f87a64b58ea0
b0426 · item pageyes1
materializeditemWHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children
item/9efbe823-0f14-4ac3-a60a-352ae72f88d7
10665-43699 · item pageyes2
materializeditemDirectriz de la OMS: recomendaciones sobre intervenciones digitales para fortalecer los sistemas de salud
item/9fa686c9-6234-4642-bab6-ee89e35273e4
10665-354399 · item pageyes2
materializeditemFourth report of Committee A
item/9fe38765-a3cb-4c0c-b5b1-560202f8aba0
10665-162250 · item pageyes2
materializeditemToolkit for analysis and use of routine health facility data: integrated health services analysis: district and facility level
item/a013176b-cb29-41d1-bb3a-d2d4ef161cd3
10665-369381 · item pageyes2
materializeditemWHO technical brief: preventing HIV during pregnancy and breastfeeding in the context of PrEP
item/a123adbf-66d3-4afe-b994-a20e0b05bf35
10665-255866 · item pageyes2
materializeditemWHO operational handbook on tuberculosis: module 5: management of tuberculosis in children and adolescents
item/a1882737-6495-4369-9c7a-117c5fe1f166
10665-352523 · item pageyes2
materializeditemGuidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV
item/a406080b-d37f-456d-9663-fe74b17a0e04
10665-357088 · item pageyes2
materializeditemSexual and reproductive health and rights: infographic snapshot: Kuwait 2021
item/a619f2a2-dad9-45eb-a31a-81ac93e303f2
10665-349570 · item pageyes2
materializeditemWHO recommendations: optimizing health worker roles to improve access to key maternal and newborn health interventions through task shifting
item/a63c34eb-807a-4ee9-b61b-8b36a6a1e64a
10665-77764 · item pageyes4
materializeditemSurvival, plasma HIV-1 RNA concentrations and drug resistance in HIV-1-infected Haitian adolescents and young adults on antiretrovirals
item/a63e52c0-1094-42fd-9f22-e8cb9cc146a6
10665-270347 · item pageyes2
materializeditemTwo years of work that can transform the health system in a fragile setting: WHO’s response to COVID-19 in Somalia, 2020–2022: road to an inclusive recovery
item/a791249e-edfc-475f-82b0-a0c8d2b53b3c
10665-365881 · item pageyes2
materializeditemGlobal smallpox vaccine reserve: report by the Secretariat
item/a80399cd-d23a-4a2a-a608-cd51771bb449
10665-20231 · item pageyes2
materializeditemPhase préparatoire à l' instauration de la vaccination anti-papillomavirus : directives stratégiques à l' intention des pays
item/a871c8a9-6382-4a59-9d0e-ec8fc1f3a7fc
10665-69653 · item pageyes2
materializeditemКартирование риска желтой лихорадки и рекомендованная вакцинация для лиц, совершающих поездки
item/a8a380e4-3c6d-4ca4-967a-a2bc3eb84a2a
10665-253894 · item pageyes2
materializeditemEthics in epidemics, emergencies and disasters: research, surveillance and patient care: training manual
item/aab90633-8626-4c72-b465-d96ee05a34f0
10665-196326 · item pageyes3
materializeditemالبرنامج الموسع للتمـنـيع :تقرير مرحلي وتقييمي
item/ac8c5680-5186-4369-a13b-3dfb7ea43e87
10665-192500 · item pageyes2
materializeditemUse of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle-income countries : policy statement
item/ae4ae4f8-9322-4c48-9833-7a08aca631ef
10665-44759 · item pageyes2
materializeditemWHO editorial style manual
item/b08c6c19-315a-41a4-a9cb-8edabdbc6791
who-pub-tps-931 · item pageyes2
materializeditemPoliovirus containment: guidance to minimize risk for facilities collecting, handling or storing materials potentially infectious for polioviruses: web annex A: country and area specific poliovirus data, April 2023 update
item/b6f3812a-ff0c-40d6-ac7b-1d60797ed326
10665-371662 · item pageyes2
materializeditemGlobal hepatitis report 2026
item/b89fc26c-9fdb-465a-ae3d-a325a35bd4e7
10665-385385 · item pageyes2
materializeditemالصحــة الـرقمية
item/b8f9ca96-f1a8-4753-9a76-b39dedbd76ce
10665-279510 · item pageyes2
materializeditemNational health workforce accounts: health workforce levels and trends 2026
item/bb4009bc-943c-4116-88e3-fe4f6cf1a400
9789240122925-eng · item pageyes2
materializeditemGlobal strategy on digital health 2020-2025
item/bd23c952-ac42-4c82-b05d-d86e3228fe5a
10665-344249 · item pageyes4
materializeditemRecomendaciones provisionales para utilizar la vacuna contra la COVID-19 elaborada por Pfizer y BioNTech, BNT162b2, en el marco de la lista de uso en emergencias: orientaciones provisionales, 8 de enero de 2021
item/bf5eb00a-0238-4024-b010-be7e7cdf4848
10665-338849 · item pageyes2
materializeditemGuidelines for the prevention and control of infection with LAV/HTLV III
item/c2f7479f-fdce-451a-ab24-3a35943daa56
10665-59577 · item pageyes2
materializeditemInfections de l' appareil reproducteur : prévalence et facteurs de risques dans une région rurale du Bangladesh / Sarah Hawkes ... [et al.]
item/c5f9b5d3-db3a-4369-b271-f1834301836c
10665-72254 · item pageyes2
materializeditemCasebook on ethical issues in international health research / edited by Richard Cash [... et al]
item/c6fed24c-9852-409b-bb65-e9e3dc2c0cc6
10665-44118 · item pageyes5
materializeditemAcceptability of routine HIV counselling and testing, and HIV seroprevalence in Ugandan hospitals
item/c83f7b6a-3104-41d3-8622-c2688b1240eb
10665-270157 · item pageyes2
materializeditemNational health workforce accounts: a handbook
item/c8db7b21-da29-4432-a6d7-61ffe3b2c1c1
9789241513111-eng · item pageyes1
materializeditemNational health workforce accounts: a handbook
item/c9312a35-1eeb-46be-8482-a5fd2a94ddb9
9789240081291-eng · item pageyes1
materializeditemGlobal guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus
item/caa49deb-2f22-4797-979e-51afb11f869b
10665-349550 · item pageyes2
materializeditemOUTBREAK NEWS : Development of a vaccine effective against avian influenza H5N1 infection in humans
item/cda32344-555a-41a4-818a-e813d426fe6e
10665-232378 · item pageyes2
materializeditemPackage of care for children and adolescents with advanced HIV disease: stop AIDS: technical brief
item/cdec9b14-5e5e-4bf3-867b-16c7de71afef
10665-332907 · item pageyes2
materializeditemDigital transformation handbook for health supply chain architecture
item/ceaeb260-196c-4589-9b19-f3ec436819e6
9789240101197-eng · item pageyes2
materializeditemYELLOW-FEVER VACCINATING CENTRES FOR INTERNATIONAL TRAVEL : Amendments to 1974 publication = CENTRES DE VACCINATION CONTRE LA FIÈVRE JAUNE POUR LES VOYAGES INTERNATIONAUX : Amendements à la publication de 1974
item/d187cdfe-4424-4adb-88ea-676a3ad4bb79
10665-220369 · item pageyes2
materializeditemДоклад Исследовательской группы по выработке требований, рекомендуемых в отношении вакцины против полиомиэлита
item/d6697144-275c-4bd1-a8ac-b0a7a25d5e98
10665-174143 · item pageyes2
materializeditemГлобальная стратегия предупреждения СПИД и борьбы с ним: проект резолюции, предложенный делегациями Австралии, Бахрейна, Бельгии, Ботсваны, Бурунди, Гаити, Гамбии, Гвинеи, Дании, Заира, Зaмбии, Зимбабве, Индии, Иcландии, Италии,.Камеруна, Канады, Катара, Кении, Кувейта, Лесото, Либерии, Мапави, Мозамбика, Нидерландов, Норвегии, Объединенной Республики Танзании, Свазиленда, Сейшельских Островов, Соединенного Королевства Великобритании и Северной Ирландии, Сомали, Союза Советских Социалистических Республик, Того, Уганды, Финляндии, Франции, Чада, Швейцарии, Швеции и Эфиопии
item/d6749d8b-fb58-4a54-a72e-1a750d6aca7e
10665-202203 · item pageyes2
materializeditemWHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention
item/d6a6bd7e-b367-43d2-a82b-f5bd874d47fe
10665-94830 · item pageyes3
materializeditemGuide d’investissement pour la mise en oeuvre numérique (DIIG) : intégrer les interventions numériques dans les programmes de santé
item/d6f254c8-6c05-41fe-a1de-1c5669a9ef63
10665-353150 · item pageyes2
materializeditemRapport de situation sur les programmes techniques : lutte antitabac ; cadres de vie sains ; maladies non transmissibles ; Objectifs du Millénaire pour le développement liés à la santé ; financement de la santé ; paludisme et résistance à l'artémisinine ; Programme élargi de vaccination ; prévention et traitement du VIH/sida
item/d727403b-9c7b-4470-bae1-131a77f976b1
10665-249126 · item pageyes2
materializeditemVACCINATION CERTIFICATE REQUIREMENTS FOR INTERNATIONAL TRAVEL = CERTIFICATS DE VACCINATION EXIGÉS DANS LES VOYACES INTERNATIONAUX
item/d9761f3b-f1d0-425d-b7a7-44c528c5ec86
10665-218508 · item pageyes2
materializeditemStratégie régionale pour améliorer l'accès aux médicaments et aux vaccins dans la Méditerranée orientale, pour la période 2020-2030 : accélérer la mise en oeuvre grâce à des systèmes de réglementation plus solides
item/dc1a4e57-bd6f-4aa7-9a2c-4c278d30d57a
10665-387553 · item pageyes2
materializeditemNational health workforce accounts: implementation guide
item/dc583bce-4e95-4e27-9b2e-7b98bbe8a144
9789241514446-eng · item pageyes1
materializeditemWHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection: module 13: integrating STI services
item/ddf4508e-26de-493b-bbd7-e851f63f9635
10665-362227 · item pageyes2
materializeditemAccélération des activités de vaccination : principes de planification / déclaration conjointe OMS/FISE
item/de1fd4aa-f3ff-480a-bca6-53e5ca4f953d
10665-37905 · item pageyes2
materializeditemWHO guideline: recommendations on digital interventions for health system strengthening
item/df396062-86b0-41c4-94c7-6e04e341bce2
10665-311941 · item pageyes2
materializeditemDigital health
item/e151cc0c-fbdc-4e24-970a-ccf35c395834
10665-279505 · item pageyes2
materializeditemDeveloping health management information systems : a practical guide for developing countries
item/e15c6f2b-2082-4f06-a8a6-b4bee09871c7
10665-207050 · item pageyes2
materializeditemWHO consolidated guidelines on tuberculosis: module 5: management of tuberculosis in children and adolescents
item/e2cb1a29-69d2-4b36-b7d5-ad55684c9386
10665-352522 · item pageyes2
materializeditemMeasles and rubella elimination country profile: Slovakia
item/e4dd9d26-3d63-4c87-8181-ed92d00fa400
10665-346431 · item pageyes2
materializeditemContingency fund for emergencies: 2020 annual report
item/e9e5a483-e01a-4e08-a0d1-865868403705
10665-342236 · item pageyes2
materializeditemУкрепление национальных систем эпиднадзора в отношении элиминации кори и краснухи в Европейском регионе ВОЗ: Бонн, Германия, 8–9 декабря 2011 г.: отчет совещания
item/ebd9455c-ff8b-4129-822e-4705afc61c06
10665-374940 · item pageyes2
materializeditemThe case for investing in public health: the strengthening public health services and capacity. A key pillar of the European regional health policy framework Health 2020
item/ece9e290-5ef8-424e-b0f1-2263052388e8
10665-351406 · item pageyes2
materializeditemGuiding principles on ethical issues in HIV surveillance
item/eda263cc-33b5-4713-9e49-9c16307a8834
10665-90448 · item pageyes2
materializeditemHepatitis B immunization : introducing hepatitis B vaccine into national immunization services
item/eefb0ed5-01b1-48cf-bd3b-f24f2b8174c1
10665-66977 · item pageyes5
materializeditemVACCINATION CERTIFICATES REQUIRED BY VARIOUS COUNTRIES = CERTIFICATS DE VACCINATlON EXIGÉS PAR LES DIVERS PAYS
item/ef4180fb-1ed2-4865-bcd1-a0caa738c075
10665-209008 · item pageyes2
materializeditemHerpes simplex virus type 2 : programmatic and research priorities in developing countries : report of a WHO/UNAIDS/LSHTM workshop, London, 14-16 February 2001
item/efff8304-f8fb-4806-855e-7f489b47194d
10665-42458 · item pageyes1
materializeditemÉvaluation du lien de causalité pour les manifestations postvaccinales indésirables (MAPI). Manuel d’utilisation de la classification OMS révisée
item/f312df17-d475-456f-9281-4c8fa0baee62
10665-208888 · item pageyes2
materializeditemCountry report : country, Upper Volta
item/f498d923-fae8-414d-ac9a-da0fc4afb17c
10665-68008 · item pageyes2
materializeditemThe value of duck-embryo vaccine and high-egg-passage Flury vaccine in experimental rabies infection in guinea-pigs
item/f4bbc450-c620-4c3e-a964-7d713137954a
10665-266967 · item pageyes2
materializeditemL’OMS recommande que des approches de dépistage du VIH qui s’appuient sur les réseaux sociaux soient offertes aux populations clés, dans le cadre d’un dispositif de services aux partenaires
item/f6e09c12-7d7e-44c1-a67f-3a475d08f754
10665-331629 · item pageyes2
materializeditemCadre de préparation en cas de grippe pandémique pour l'échange des virus grippaux et l'accès aux vaccins et autres avantages
item/f97076e2-6747-4615-b977-210a939c0403
10665-44853 · item pageyes2
materializeditemDigital transformation handbook for health product catalogue
item/fd2019bb-dd79-4c1f-ac5d-9b5fadf35383
9789240116191-eng · item pageyes2
materializeditemWHO international quality assessment scheme for HIV antibody testing: results from the second distribution of sera.
item/fe014ce9-acc9-42b6-a330-f20c3a0a54d0
10665-261545 · item pageyes2
referencedcollectionTechnical Documents
collection/29e98ea0-6645-4b2d-ae90-3cb8769881b6
———
referencedcollectionTechnical Documents
collection/43c3b8d5-432d-4e1b-a5bf-3cc6129d7266
———
referencedcollectionPublications
collection/hq-publications
———
referencedcollectionInformation products
collection/wpro-information-products
———
referencedcommunity3. Regional Office for the Americas
community/270bee8e-d535-4512-86a2-b01850407a23
———
referencedcommunity8. WHO Framework Convention on Tobacco Control (FCTC)
community/28b22be0-5864-409c-9b83-0442e2a7ca0e
———
referencedcommunity1. Headquarters
community/5bff2c18-6c2b-4658-9087-93811d2399c0
———
referencedcommunity6. Regional Office for South-East Asia
community/8f327840-b0f3-4769-a1c2-270b2b5ce7da
———
referencedcommunity2. Regional Office for Africa
community/e1b206b7-fd4c-4b93-972a-be07850a1cdd
———
referencedcommunityRegional Publications
community/e938c08b-fbea-47ba-bcf4-7eebe173697d
———
referencedcommunity7. Regional Office for the Western Pacific
community/ebd3b191-c322-4754-9415-469a1a0eb0c3
———
referencedcommunity4. Regional Office for the Eastern Mediterranean
community/f005d7fc-da21-4f55-9e06-9f65c49b2184
———
referencedcommunity5. Regional Office for Europe
community/fb66a624-a5dc-4576-8b6b-929639e552d8
———
referenceditemVaccines and vaccination against yellow fever : WHO Position Paper — June 2013 = Note de synthèse : position de l’OMS sur les vaccins et la vaccination contre la fièvre jaune, juin 2013
item/0114ad8c-116d-4bbe-aad0-4b263b16501d
—yes1
referenceditemTyphoid vaccines: WHO position paper – March 2018 – Vaccins antityphoïdiques: note de synthèse de l’OMS – mars 2018
item/0574f940-4944-4a8d-ba60-3d221d0a5bc4
—yes1
referenceditemConsiderations for pneumococcal vaccination in older adults – Considérations relatives à la vaccination antipneumococcique chez les personnes âgées
item/09121386-886a-4c07-87cc-a5f0dfba3297
—yes1
referenceditemProtecting all against tetanus: guide to sustaining maternal and neonatal tetanus elimination (MNTE) and broadening tetanus protection for all populations
item/09f6c202-64f2-4f91-bbc7-862f4fc28f47
—yes2
referenceditemRotavirus vaccines: WHO position paper – July 2021 – Vaccins antirotavirus : note de synthèse de l’OMS – Juillet 2021
item/0c81a294-c943-40a5-b3c2-989dfac3d72c
—yes1
referenceditemCholera vaccines: WHO position paper – August 2017 – Vaccins anticholériques: Note de synthèse de l’OMS – août 2017
item/0d7346d9-b413-4ba3-a02e-de06e2a9d03e
—yes1
referenceditemJapanese Encephalitis Vaccines : WHO position paper — February 2015 = Note de synthèse : position de l’OMS à propos des vaccins contre l’encéphalite japonaise — février 2015
item/12cd0b5d-f341-41f3-b325-0ee5873439ce
—yes1
referenceditemConsolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach
item/1c992591-c558-4371-a07c-d243f65ef1d4
—yes2
referenceditemMeasles vaccines: WHO position paper – April 2017 – Note de synthèse de l’OMS sur les vaccins contre la rougeole – avril 2017
item/20382594-e79f-46bf-813f-0907514235ba
—yes1
referenceditemPneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper –February 2019 ─ Vaccins antipneumococciques conjugués chez les nourrissons et les enfants de moins de 5 ans: note de synthèse de l’OMS – février 2019
item/260b9ae2-b1e7-4b25-8b00-3cd51a0583bc
—yes1
referenceditemDigital adaptation kit for HIV: operational requirements for implementing: WHO recommendations in digital systems: web annex B: decision-support logic
item/2eb1b50c-b8b1-42ff-839b-d89fb8eba783
—yes1
referenceditemBCG vaccines: WHO position paper – February 2018 – Vaccins BCG: Note de synthèse de l’OMS – Février 2018
item/37c611b2-91f0-494e-b1a3-a663728c3d65
—yes1
referenceditemWHO position paper on hepatitis A vaccines – October 2022 – Note de synthèse: position de l’OMS concernant les vaccins contre l’hépatite A – Octobre 2022
item/4e3d25a8-7f40-44cc-8740-21e1c9ff07ad
—yes1
referenceditemMeningococcal vaccines : WHO position paper, November 2011 = Note de synthèse : position de l’OMS sur les vaccins antiméningococciques, novembre 2011
item/5197f02e-bfbe-47ec-9897-3c3b1553ca80
—yes1
referenceditemHepatitis B vaccines: WHO position paper – July 2017 – Vaccins anti-hépatite B: note de synthèse de l’OMS – juillet 2017
item/52c9a2f4-b633-4221-9ee6-9306b8125081
—yes1
referenceditemPertussis vaccines : WHO position paper — August 2015 = Note de synthèse : Position de l’OMS concernant les vaccins anticoquelucheux — août 2015
item/55894c3a-f746-4699-abdd-b4423ec5e13d
—yes1
referenceditemDigital adaptation kit for HIV: operational requirements for implementing WHO recommendations in digital systems
item/59e7ed01-0bb9-4729-ad54-b08f3a4ef850
—yes2
referenceditemVaccines against influenza: WHO position paper – May 2022 – Vaccins antigrippaux: note de synthèse de l’OMS – mai 2022
item/5ec5d7e8-18fa-4299-b232-1d9ea7aa985a
—yes1
referenceditemLes maladies transmissibles / Giorgio Torrigiani et William Parra
item/620b57d1-7397-4033-a0f4-5bbd96d4357a
—yes—
referenceditemDigital adaptation kit for HIV: operational requirements for implementing: WHO recommendations in digital systems: web annex D: function and non-functional requirements
item/66c55c00-687a-495c-baa7-976e779bfd4a
—yes1
referenceditemDigital adaptation kit for HIV: operational requirements for implementing: WHO recommendations in digital systems: web annex C: indicators table
item/825149ca-2e0e-4875-baa8-37138bd924b9
—yes1
referenceditemRequirements for rabies vaccine for human use produced in continuous cell lines : requirements for Biological Substances 22 (revised 1986
item/82939e05-8b13-4943-9b86-a1cecb5ed646
—yes—
referenceditemReports on individual drugs
item/89239ad6-c81b-497d-8769-8f40655e5364
—yes—
referenceditemConsolidated HIV guidelines: service delivery
item/8c4885b7-edf2-4608-9bf7-4a64303314cf
—yes2
referenceditemMalaria vaccine: WHO position paper – March 2022 – Rapport mensuel des cas de dracunculose, janvier 2022
item/9384a5ff-b9aa-4316-8be2-260d1bd5b163
—yes1
referenceditemVaricella and herpes zoster vaccines : WHO position paper, June 2014 = Vaccins contre la varicelle et le zona : note de synthèse de l’OMS, juin 2014
item/9fcfab8c-4a0b-4de4-a45a-80b9236cecb4
—yes1
referenceditemHaemophilus influenzae type b (Hib) Vaccination Position Paper — July 2013 : Introduction = Note de synthèse : Position de l’OMS sur la vaccination anti-Haemophilus influenzae type b (Hib) — Juillet 2013 : Introduction
item/a379a0e2-245a-49c4-a789-d2577494717f
—yes1
referenceditemProgress towards better vaccines : proceedings of a meeting organized by the World Health Organization as part of the Programme for Vaccine Development, held in Bellagio, Italy, by courtesy of the Rockefeller Foundation 16-18 April 1985 / edited by Rosemary Bell and G. Torrigiani
item/abbffc39-5e65-44fd-b348-1f7ffbdadb26
—yes—
referenceditemDigital adaptation kit for HIV: operational requirements for implementing: WHO recommendations in digital systems: web annex A: data dictionary
item/acec3fa7-837a-4b88-9ab1-00397f313827
—yes1
referenceditemTetanus vaccines: WHO position paper – February 2017 = Note de synthèse: position de l’OMS sur les vaccins antitétaniques – février 2017
item/ad94cc6a-a452-4df4-ac93-8fb9f6ed6726
—yes1
referenceditemDengue vaccine: WHO position paper – September 2018 – Note de synthèse de l’OMS sur le vaccin contre la dengue– septembre 2018
item/b357fcec-bc11-498b-a45d-fa4d1862133d
—yes1
referenceditemHuman papillomavirus vaccines: WHO position paper (2022 update) –Vaccins contre les papillomavirus humains: note de synthèse de l’OMS (mise à jour de 2022)
item/ba4725de-c977-42f9-8836-0b50b689036f
—yes1
referenceditemMeningococcal A conjugate vaccine : updated guidance, February 2015 = Vaccin antiméningococcique conjugué contre le sérogroupe A : orientations actualisées, février 2015
item/c5122024-a534-417b-b8d6-6fc5f2596845
—yes1
referenceditemConsolidated guidelines on HIV testing services, 2019
item/d0fe15da-15f9-4ba5-bfe4-73658e98db6a
—yes2
referenceditemPolio vaccines: WHO position paper – June 2022 – Vaccins antipoliomyélitiques: note de synthèse de l’OMS – juin 2022
item/d5862fee-c17d-47f7-b987-948bd1c3013f
—yes1
referenceditemRabies vaccines: WHO position paper – April 2018 – Vaccins antirabiques: Note de synthèse de l’OMS – avril 2018
item/e1b5ebde-ac69-4af8-81be-a65792681f98
—yes1
referenceditemConsolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach
item/e1d59705-e50f-4e1a-b344-0c8a2ec8003b
—yes1
referenceditemVaccines against tick-borne encephalitis : WHO position paper = Note de synthèse : position de l'OMS sur les vaccins contre l'encéphalite à tiques
item/e6962e46-4c85-4a11-abd3-d4330c450fe4
—yes1
referenceditemRubella vaccines: WHO position paper – July 2020 – Note de synthèse: position de l’OMS concernant les vaccins antirubéoleux
item/f32dcd1b-769c-434d-9728-72987d72c7ae
—yes1
referenceditemMumps virus vaccines = Vaccins anti-ourliens
item/f6dea5c1-7b95-4f4a-be6e-8fefeb04dd95
—yes1

Generated from catalogue/ by who-iris/scripts/gen-iris-pages.ts. Every count above is derived from the nodes themselves; none is transcribed. bun run cat check:catalogue separately verifies that each node validates and that every metadataRef, libraryId, localPath and parent path resolves — so this page reports what the catalogue says, and that check reports whether it hangs together.


folio-assistant — code under the Apache License 2.0, documentation under CC BY 3.0. Generated schema and API references are rebuilt from source on every push to main.

deployed dev